生酮饮食在神经系统疾病中应用的研究进展

doi:10.20047/j.issn1673-7210.2023.20.11

Abstract
Figure/Table
References (37)
Related Citation (2)

Download: PDF (570 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract The pathogenesis of nervous system diseases is complex, and the clinical symptoms are lingering and difficult to cure, which seriously affect the quality of life of patients. At present, the treatment of nervous system diseases by changing dietary habits is an important intervention route. As an effective diet, ketogenic diet is first used in the control of refractory epilepsy and gradually extended to other neurological diseases. This paper reviews the research progress of ketogenic diet in the treatment of epilepsy, Alzheimer’s disease, Parkinson disease, migraine, multiple sclerosis, amyotrophic lateral sclerosis, and other neurological diseases, summarize the mechanism of action and analyze the application status, in order to provide new ideas for the optimization of keto genic diet and the treatment of nervous system diseases.

Key words： Ketogenic diet Nervous system diseases Ketone body Dietary intervention

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHU Jinyi1 YIN Jiantao1 ZHANG Miao2

Cite this article:

ZHU Jinyi1 YIN Jiantao1 ZHANG Miao2. Research progress in the application of ketogenic diet in nervous system diseases[J]. 中国医药导报, 2023, 20(20): 56-59.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.20.11 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I20/56

[1] Dowis K，Banga S. The Potential Health Benefits of the Ketogenic Diet：A Narrative Review [J]. Nutrients，2021，13（5）：1654.
[2] 刘春红，靳力，王正平，等.中链甘油三酯生酮饮食在神经退行性疾病治疗中的应用[J].聊城大学学报（自然科学版），2020，33（1）：85-91.
[3] Puchalska P，Crawford PA. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism，Signaling，and Therapeutics [J]. Cell Metab，2017，25（2）：262-284.
[4] Barzegar M，Afghan M，Tarmahi V，et al. Ketogenic diet： over- view，types，and possible anti-seizure mechanisms [J]. Nutr Neurosci，2021，24（4）：307-316.
[5] Han FY，Conboy-Schmidt L，Rybachuk G，et al. Dietary med- ium chain triglycerides for management of epilepsy： New data from human，dog，and rodent studies [J]. Epilepsia，2021， 62（8）：1790-1806.
[6] Ko A，Kwon HE，Kim HD. Updates on the ketogenic diet therapy for pediatric epilepsy [J]. Biomed J，2022，45（1）：19-26.
[7] Ang QY，Alexander M，Newman JC，et al. Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells [J]. Cell，2020，181（6）：1263-1275.
[8] Verrotti A，Iapadre G，Di Francesco L，et al. Diet in the Treatment of Epilepsy：What We Know So Far [J]. Nutrients，2020， 12（9）：2645.
[9] Baby N，Vinayan KP，Pavithran N，et al. A pragmatic study on efficacy，tolerability and long term acceptance of ketogenic diet therapy in 74 South Indian children with pharmacoresistant epilepsy [J]. Seizure，2018，58：41-46.
[10] 苏绮璇，侯小兵.生酮饮食添加疗法对药物难治性癫痫儿童的疗效与生活质量的影响[J].临床神经病学杂志，2021，34（1）：5-9.
[11] Zare M，Okhovat AA，Esmaillzadeh A，et al. Modified Atkins diet in adult with refractory epilepsy：A controlled randomized clinical trial [J]. Iran J Neurol，2017，16（2）：72-77.
[12] Cervenka MC，Hocker S，Koenig M，et al. Phase Ⅰ/Ⅱ mult- icenter ketogenic diet study for adult superrefractory status epilepticus [J]. Neurology，2017，88（10）：938-943.
[13] Poelzer K，Mannion C，Ortiz MM，et al. A Systematic Review of the Quality of Life for Families Supporting a Child Consuming the Ketogenic Diet for Seizure Reduction [J]. Curr Dev Nutr，2018，3（5）：nzz079.
[14] Martin-McGill KJ，Bresnahan R，Levy RG，et al. Ketogenic diets for drug-resistant epilepsy [J]. Cochrane Database Syst Rev，2020，6（6）：CD001903.
[15] Lilamand M，Mouton-Liger F，Di Valentin E，et al. Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer’s Disease： A Mini Review [J]. Front Nutr，2022，8：807970.
[16] Xu Y，Jiang C，Wu J，et al. Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer’s disease [J]. CNS Neurosci Ther，2022，28（4）：580-592.
[17] 张营丽，周艳华，李卓，等.生酮饮食对阿尔茨海默病患者神经损伤及焦虑抑郁情绪的影响[J].中国实用神经疾病杂志，2021，24（1）：49-53.
[18] Phillips MCL，Deprez LM，Mortimer GMN，et al. Randomized crossover trial of a modified ketogenic diet in Alzh- eimer’s disease [J]. Alzheimers Res Ther，2021，13（1）：51.
[19] Ohnuma T，Toda A，Kimoto A，et al. Benefits of use，and tolerance of，medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease：a prospective，open-label pilot study [J]. Clin Interv Aging，2016，11：29-36.
[20] Grochowska K，Przeliorz A. The Effect of the Ketogenic Diet on the Therapy of Neurodegenerative Diseases and Its Impact on Improving Cognitive Functions [J]. Dement Geriatr Cogn Dis Extra，2022，12（2）：100-106.
[21] Shaafi S，Najmi S，Aliasgharpour H，et al. The efficacy of the ketogenic diet on motor functions in Parkinson’s disease：A rat model [J]. Iran J Neurol，2016，15（2）：63-69.
[22] Sivanandy P，Leey TC，Xiang TC，et al. Systematic Review on Parkinson’s Disease Medications，Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Sympto- ms [J]. Int J Environ Res Public Health，2021，19（1）：364.
[23] Phillips MCL，Murtagh DKJ，Gilbertson LJ，et al. Low-fat versus ketogenic diet in Parkinson’s disease： A pilot randomized controlled trial [J]. Mov Disord，2018，33（8）：1306- 1314.
[24] Koyuncu H，Fidan V，Toktas H，et al. Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson’s disease [J]. Acta Neurol Belg，2021，121（6）：1729- 1732.
[25] Barbanti P，Fofi L，Aurilia C，et al. Ketogenic diet in migraine： rationale，findings and perspectives [J]. Neurol Sci，2017，38（Suppl 1）：111-115.
[26] Di Lorenzo C，Coppola G，Sirianni G，et al. Migraine improvement during short lasting ketogenesis： a proof-of- concept study [J]. Eur J Neurol，2015，22（1）：170-177.
[27] Bongiovanni D，Benedetto C，Corvisieri S，et al. Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine [J]. Neurol Sci，2021，42（9）：3865-3870.
[28] Lovati C，d’Alessandro CM，Ventura SD，et al. Ketogenic diet in refractory migraine： possible efficacy and role of ketone bodies-a pilot experience [J]. Neurol Sci，2022，43（11）： 6479-6485.
[29] Putananickal N，Gross EC，Orsini AL，et al. Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine：A single-centred，rando- mised，placebo-controlled，double-blind crossover trial [J]. Cephalalgia，2022，42（4/5）：302-311.
[30] Di Lorenzo C，Coppola G，Di Lenola D，et al. Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache： An Open-Label，Single-Arm，Clinical Trial [J]. Front Neurol，2018，9：64.
[31] Lavado A，Guo X，Smith AS，et al. Evaluation of Holistic Treatment for ALS Reveals Possible Mechanism and Therapeutic Potential [J]. Int J Pharm Pharm Res，2017，11（1）：348-374.
[32] Demirel A，Li J，Morrow C，et al. Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury：study protocol for a randomized controlled trial [J]. Trials，2020，21（1）：372.
[33] Har-Even M，Rubovitch V，Ratliff WA，et al. Ketogenic Diet as a potential treatment for traumatic brain injury in mice [J]. Sci Rep，2021，11（1）：23559.
[34] Bahr LS，Bock M，Liebscher D，et al. Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis （NAMS）：protocol of a randomized controlled study [J]. Trials，2020，21（1）：3.
[35] Choi IY，Piccio L，Childress P，et al. A Diet Mimicking Fas- ting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms [J]. Cell Rep，2016，15（10）：2136-2146.
[36] Swidsinski A，D?觟rffel Y，Loening-Baucke V，et al. Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet [J]. Front Microbiol，2017，8：1141.
[37] 王慧，马静萍.生酮饮食治疗癫痫的研究进展[J].中西医结合心脑血管病杂志，2021，19（22）：3923-3926.